Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) Antibody Responses in Children With Multisystem Inflammatory Syndrome in Children (MIS-C) and Mild and Severe Coronavirus Disease 2019 (COVID-19)

doi:10.1093/jpids/piaa161

. 2021 May 28;10(5):669-673.

doi: 10.1093/jpids/piaa161.

Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) Antibody Responses in Children With Multisystem Inflammatory Syndrome in Children (MIS-C) and Mild and Severe Coronavirus Disease 2019 (COVID-19)

Elizabeth M Anderson¹, Caroline Diorio^{2

3}, Eileen C Goodwin¹, Kevin O McNerney^{2

3}, Madison E Weirick¹, Sigrid Gouma¹, Marcus J Bolton¹, Claudia P Arevalo¹, Julie Chase^{2

4}, Philip Hicks^{1

5}, Tomaz B Manzoni¹, Amy E Baxter^{6

7}, Kurt P Andrea^{6

7}, Chakkapong Burudpakdee², Jessica H Lee², Laura A Vella^{6

7

8}, Sarah E Henrickson⁹, Rebecca M Harris¹⁰, E John Wherry^{6

7}, Paul Bates^{1

11}, Hamid Bassiri^{2

8}, Edward M Behrens^{2

4}, David T Teachey^{2

3}, Scott E Hensley¹

Affiliations

¹ Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
² Immune Dysregulation Frontier Program, Department of Pediatrics, Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
³ Department of Pediatrics, Division of Oncology, Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
⁴ Department of Pediatrics, Division of Rheumatology, Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
⁵ School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
⁶ Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
⁷ Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
⁸ Department of Pediatrics, Division of Infectious Diseases, Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
⁹ Department of Pediatrics, Division of Allergy and Immunology, Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
¹⁰ Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
¹¹ Penn Center for Research on Coronavirus and Other Emerging Pathogens, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

PMID: 33263756
PMCID: PMC7799010
DOI: 10.1093/jpids/piaa161

Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) Antibody Responses in Children With Multisystem Inflammatory Syndrome in Children (MIS-C) and Mild and Severe Coronavirus Disease 2019 (COVID-19)

Elizabeth M Anderson et al. J Pediatric Infect Dis Soc. 2021.

. 2021 May 28;10(5):669-673.

doi: 10.1093/jpids/piaa161.

Authors

Affiliations

¹ Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
² Immune Dysregulation Frontier Program, Department of Pediatrics, Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
³ Department of Pediatrics, Division of Oncology, Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
⁴ Department of Pediatrics, Division of Rheumatology, Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
⁵ School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
⁶ Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
⁷ Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
⁸ Department of Pediatrics, Division of Infectious Diseases, Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
⁹ Department of Pediatrics, Division of Allergy and Immunology, Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
¹⁰ Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
¹¹ Penn Center for Research on Coronavirus and Other Emerging Pathogens, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

PMID: 33263756
PMCID: PMC7799010
DOI: 10.1093/jpids/piaa161

Abstract

Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) antibody responses in children remain poorly characterized. Here, we show that pediatric patients with multisystem inflammatory syndrome in children (MIS-C) possess higher SARS-CoV-2 spike immunoglobulin G (IgG) titers compared with those with severe coronavirus disease 2019, likely reflecting a longer time since the onset of infection in MIS-C patients.

Keywords: COVID-19; SARS-COV-2; antibodies; multisystem inflammatory syndrome in children (MIS-C); pediatric.

© The Author(s) 2020. Published by Oxford University Press on behalf of The Journal of the Pediatric Infectious Diseases Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

PubMed Disclaimer

Update of

SARS-CoV-2 antibody responses in children with MIS-C and mild and severe COVID-19.
Anderson EM, Diorio C, Goodwin EC, McNerney KO, Weirick ME, Gouma S, Bolton MJ, Arevalo CP, Chase J, Hicks P, Manzoni TB, Baxter AE, Andrea KP, Burudpakdee C, Lee JH, Vella LA, Henrickson SE, Harris RM, Wherry EJ, Bates P, Bassiri H, Behrens EM, Teachey DT, Hensley SE. Anderson EM, et al. medRxiv [Preprint]. 2020 Aug 18:2020.08.17.20176552. doi: 10.1101/2020.08.17.20176552. medRxiv. 2020. Update in: J Pediatric Infect Dis Soc. 2021 May 28;10(5):669-673. doi: 10.1093/jpids/piaa161. PMID: 32839782 Free PMC article. Updated. Preprint.

Cited by

The Multifaceted Manifestations of Multisystem Inflammatory Syndrome during the SARS-CoV-2 Pandemic.
Pérez-Gómez HR, Morfín-Otero R, González-Díaz E, Esparza-Ahumada S, León-Garnica G, Rodríguez-Noriega E. Pérez-Gómez HR, et al. Pathogens. 2022 May 8;11(5):556. doi: 10.3390/pathogens11050556. Pathogens. 2022. PMID: 35631077 Free PMC article. Review.
Current Insights Into the Pathophysiology of Multisystem Inflammatory Syndrome in Children.
Vella LA, Rowley AH. Vella LA, et al. Curr Pediatr Rep. 2021;9(4):83-92. doi: 10.1007/s40124-021-00257-6. Epub 2021 Oct 19. Curr Pediatr Rep. 2021. PMID: 34692237 Free PMC article. Review.
SARS-CoV-2 Antibody Responses in Pediatric Patients: A Bibliometric Analysis.
Maniu I, Maniu GC, Antonescu E, Duica L, Grigore N, Totan M. Maniu I, et al. Biomedicines. 2023 May 16;11(5):1455. doi: 10.3390/biomedicines11051455. Biomedicines. 2023. PMID: 37239126 Free PMC article. Review.
Protective SARS-CoV-2 Antibody Response in Children With Inflammatory Bowel Disease.
Bosa L, Di Chiara C, Gaio P, Cosma C, Padoan A, Cozzani S, Perilongo G, Plebani M, Giaquinto C, Donà D, Cananzi M. Bosa L, et al. Front Pediatr. 2022 Feb 10;10:815857. doi: 10.3389/fped.2022.815857. eCollection 2022. Front Pediatr. 2022. PMID: 35223697 Free PMC article.
The complex landscape of immune dysregulation in multisystem inflammatory syndrome in children with COVID-19.
Guo J, Wang L. Guo J, et al. Life Med. 2024 Sep 13;3(4):lnae034. doi: 10.1093/lifemedi/lnae034. eCollection 2024 Aug. Life Med. 2024. PMID: 39872865 Free PMC article. Review.

See all "Cited by" articles

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) Antibody Responses in Children With Multisystem Inflammatory Syndrome in Children (MIS-C) and Mild and Severe Coronavirus Disease 2019 (COVID-19)

Affiliations

Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) Antibody Responses in Children With Multisystem Inflammatory Syndrome in Children (MIS-C) and Mild and Severe Coronavirus Disease 2019 (COVID-19)

Authors

Affiliations

Abstract

Update of

Similar articles

Cited by

MeSH terms

Substances

Supplementary concepts

Grants and funding

LinkOut - more resources

Full Text Sources

Medical

Miscellaneous

Abstract

Update of

Similar articles

Cited by

MeSH terms

Substances

Supplementary concepts

Related information

Grants and funding

LinkOut - more resources

Full Text Sources

Medical

Miscellaneous